HC Wainwright & Co. analyst Raghuram Selvaraju downgrades Provention Bio (NASDAQ:PRVB) from Buy to Neutral and raises the price target from $16 to $25.
Raymond James analyst Brian Peterson downgrades Qualtrics International Inc (NASDAQ:XM) from Outperform to Market Perform. Silver Lake and CPP Investment agreed to…
Wells Fargo analyst Brian Fitzgerald downgrades Momentive Glb (NASDAQ:MNTV) from Overweight to Equal-Weight and lowers the price target from $10 to $9.46.